Does Chordoma have a cure?

Currently, there is no single standardized "cure" for chordoma, a rare slow-growing bone cancer arising from notochord remnants. While the disease is challenging to eradicate due to its location near critical structures like the brainstem and spinal cord, current multidisciplinary approaches focus on achieving long-term local control, managing recurrence, and improving quality of life.

What are the current treatment standards for chordoma?

Treatment for chordoma is highly specialized and generally involves a combination of surgery and radiation therapy. Because chordoma is notoriously resistant to conventional chemotherapy, the primary goal is "maximal safe resection"—removing as much of the tumor as possible without damaging surrounding nerves or tissue. Following surgery, high-dose radiation, such as proton beam therapy or carbon ion therapy, is often used to target microscopic residual disease and reduce the risk of local recurrence.

What research is shaping the future of chordoma care?

Research is accelerating, with a focus on molecular pathways that drive chordoma growth. Scientists are currently investigating several promising avenues:

• Targeted Therapies: Research into inhibitors targeting the brachyury protein, a key driver of chordoma, remains a major focus.


• Immunotherapy: Trials exploring immune checkpoint inhibitors are evaluating if the body’s immune system can be trained to recognize and attack tumor cells.


• Precision Medicine: Genomic profiling is helping researchers identify specific mutations that might make a patient a candidate for repurposed FDA-approved medications.

How can patients find and participate in clinical trials?

Participation in clinical trials is vital for advancing chordoma research. Patients should consult with a specialized sarcoma center to discuss active trials. Currently, studies are focusing on systemic therapies for metastatic or unresectable chordoma. The Chordoma Foundation maintains a real-time database of open trials, which is the most reliable way to track potential breakthroughs and eligibility criteria.

Next steps

• Consult with a multidisciplinary team at a center of excellence that specializes in skull base or sacral tumors.


• Join the chordoma community at DiseaseMaps.org to connect with the 34 members currently sharing their experiences and treatment journeys.


• Register with the Chordoma Foundation to receive updates on emerging clinical trials and patient advocacy opportunities.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your physician for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Chordoma


• Orphanet - Rare disease information for Chordoma


• Chordoma Foundation - Research and Clinical Trials Database


• National Cancer Institute (NCI) - Rare Tumors and Sarcoma Research